← Back to headlines
Novo Nordisk Faces Generic Competition for Weight-Loss Drugs
Despite a significant share price drop, Zealand Pharma's CEO remains optimistic, while Novo Nordisk anticipates competition from cheaper generic versions of its weight-loss drugs entering major markets this year.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Volkswagen Plans to Cut 100,000 Jobs and Quarter of Management
19m ago
DAZN Acquires EverPass Media to Expand U.S. Sports Streaming Footprint
21m ago
Vanguard Finalizes Acquisition Deal for Fintech Platform Altruist
28m ago
Corporate Earnings Show Mixed Results as Kohl's Sales Slide Amid Strong Tech Gains
29m ago